Reform of drug regulation--beyond an independent drug-safety board

N Engl J Med. 2006 Jan 12;354(2):194-201. doi: 10.1056/NEJMsb053432.
No abstract available

MeSH terms

  • Adverse Drug Reaction Reporting Systems
  • Drug Approval / organization & administration
  • Drug Industry
  • Drug and Narcotic Control* / organization & administration
  • Health Care Reform*
  • Product Surveillance, Postmarketing*
  • United States
  • United States Food and Drug Administration